Header

UZH-Logo

Maintenance Infos

Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin


Carradori, Dario; Chen, Hsintsung; Werner, Beat; Shah, Aagam S; Leonardi, Chiara; Usuelli, Mattia; Mezzenga, Raffaele; Platt, Frances; Leroux, Jean‐Christophe (2020). Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann‐Pick Disease Type C Using Crosslinked 2‐Hydroxypropyl‐β‐cyclodextrin. Small, 16(46):2004735.

Abstract

Niemann‐Pick disease type C (NPC) is a severe disorder that is characterized by intracellular transport abnormalities leading to cytoplasmic accumulation of lipids such as cholesterol and sphingolipids. The compound 2‐hydroxypropyl‐β‐cyclodextrin (HPβCD) has high cholesterol complexation capacity and is currently under clinical investigation for the NPC treatment. However, due to its short blood half‐life, high doses are required to produce a therapeutic effect. In this work, stable polymerized HPβCD is generated to investigate their in vitro mechanisms of action and in vivo effects. Crosslinked CDs (8–312 kDa) display a ninefold greater cholesterol complexation capacity than monomeric HPβCD but are taken up to a lower extent, resulting in an overall comparable in vitro effect. In vivo, the 19.3 kDa HPβCD exhibits a longer half‐life than the monomeric HPβCD but it does not increase the life span of Npc1 mice, possibly due to reduced brain penetration. This is circumvented by the application of magnetic resonance imaging‐guided low intensity‐pulsed focused ultrasound (MRIg‐FUS), which increases the brain penetration of the CD. In conclusion, stable polymerized HPβCDs can elucidate CDs’ mechanism of action while the use of MRIg‐FUS warrants further investigation, as it may be key to harnessing CDs full therapeutic potential in the NPC treatment.

Abstract

Niemann‐Pick disease type C (NPC) is a severe disorder that is characterized by intracellular transport abnormalities leading to cytoplasmic accumulation of lipids such as cholesterol and sphingolipids. The compound 2‐hydroxypropyl‐β‐cyclodextrin (HPβCD) has high cholesterol complexation capacity and is currently under clinical investigation for the NPC treatment. However, due to its short blood half‐life, high doses are required to produce a therapeutic effect. In this work, stable polymerized HPβCD is generated to investigate their in vitro mechanisms of action and in vivo effects. Crosslinked CDs (8–312 kDa) display a ninefold greater cholesterol complexation capacity than monomeric HPβCD but are taken up to a lower extent, resulting in an overall comparable in vitro effect. In vivo, the 19.3 kDa HPβCD exhibits a longer half‐life than the monomeric HPβCD but it does not increase the life span of Npc1 mice, possibly due to reduced brain penetration. This is circumvented by the application of magnetic resonance imaging‐guided low intensity‐pulsed focused ultrasound (MRIg‐FUS), which increases the brain penetration of the CD. In conclusion, stable polymerized HPβCDs can elucidate CDs’ mechanism of action while the use of MRIg‐FUS warrants further investigation, as it may be key to harnessing CDs full therapeutic potential in the NPC treatment.

Statistics

Citations

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
07 Faculty of Science > Institute of Neuroinformatics
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Life Sciences > Biotechnology
Physical Sciences > Biomaterials
Physical Sciences > General Chemistry
Physical Sciences > General Materials Science
Uncontrolled Keywords:Biotechnology, Engineering (miscellaneous), Biomaterials
Language:English
Date:1 November 2020
Deposited On:27 Oct 2020 11:42
Last Modified:15 Feb 2021 15:38
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:1613-6810
OA Status:Closed
Publisher DOI:https://doi.org/10.1002/smll.202004735
PubMed ID:33079457

Download

Full text not available from this repository.
View at publisher

Get full-text in a library